Myomo (MYO) Other Non Operating Income (2016 - 2025)
Myomo (MYO) posted Other Non Operating Income of -$9743.0 for Q3 2025, down 109.14% on a QoQ basis from $106549.0 in Q2 2025, and down 112.82% year-over-year from $76020.0 in Q3 2024.
Myomo (MYO) Other Non Operating Income (2016 - 2025) Analysis & Trends
Myomo's Other Non Operating Income history runs 10 years deep, the most recent figure standing at -$9743.0 for Q3 2025.
- Quarterly Other Non Operating Income fell 112.82% year-over-year to -$9743.0 in Q3 2025, while the trailing twelve-month figure through Sep 2025 was -$221749.0 (down 148.34% YoY) and the FY2023 annual result came in at $239986.0, up 460.82% from the prior year.
- Other Non Operating Income was -$9743.0 for Q3 2025 at Myomo, down from $106549.0 in the prior quarter.
- Across five years, Other Non Operating Income topped out at $140146.0 in Q4 2023 and bottomed at -$318555.0 in Q4 2024.
- A 5-year average of $13578.7 and a median of -$119.0 in 2021 frame the typical range for Other Non Operating Income.
- Annual changes were most pronounced in 2022 — Other Non Operating Income plunged 852.63% — and 2024, when it jumped 886.5%.
- Myomo's Other Non Operating Income stood at -$5143.0 in 2021, then plunged by 852.63% to -$48994.0 in 2022, then surged by 386.05% to $140146.0 in 2023, then slumped by 327.3% to -$318555.0 in 2024, then surged by 96.94% to -$9743.0 in 2025.
- Business Quant data shows MYO's Other Non Operating Income at -$9743.0 in Q3 2025, $106549.0 in Q2 2025, and -$318555.0 in Q4 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.32 Bn | 175.02 Bn | 6.27 Bn |
| 2 | Stryker | 128.75 Bn | 125.88 Bn | 3.81 Bn |
| 3 | Medtronic | 107.83 Bn | 98.61 Bn | 6.41 Bn |
| 4 | Boston Scientific | 67.61 Bn | 66.15 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 48.13 Bn | 44.45 Bn | 1.29 Bn |
| 6 | Dexcom | 28.26 Bn | 27.14 Bn | 750.30 Mn |
| 7 | GE HealthCare Technologies | 27.78 Bn | 25.50 Bn | 1.98 Bn |
| 8 | Smith & Nephew | 26.99 Bn | 26.41 Bn | - |
| 9 | Koninklijke Philips | 23.92 Bn | 20.80 Bn | 2.07 Bn |
| 10 | Myomo | 43.43 Mn | 24.46 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | -9,743.00 |
| Jun 30, 2025 | 106,549.00 |
| Dec 31, 2024 | -318,555.00 |
| Sep 30, 2024 | 76,020.00 |
| Jun 30, 2024 | 107,242.00 |
| Mar 31, 2024 | 135,293.00 |
| Dec 31, 2023 | 140,146.00 |
| Sep 30, 2023 | 70,124.00 |
| Jun 30, 2023 | 12,514.00 |
| Mar 31, 2023 | -17,202.00 |
| Dec 31, 2022 | -48,994.00 |
| Sep 30, 2022 | 12,307.00 |
| Jun 30, 2022 | -19,528.00 |
| Dec 31, 2021 | -5,143.00 |
| Sep 30, 2021 | -4,055.00 |
| Jun 30, 2021 | -6,018.00 |
| Mar 31, 2021 | -119.00 |
| Dec 31, 2020 | -831,928.00 |
| Sep 30, 2020 | 888.00 |
| Jun 30, 2020 | 39,717.00 |